Re: Who they are: Gerber Scientific
in response to
by
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Who they are: Gerber Scientific
GERBER SCIENTIFIC
(NYSE: GRB)
Last Trade:
7.96
Trade Time:
3:51PM ET
Change:
0.12 (1.53%)
Prev Close:
7.84
Open:
7.61
Bid:
N/A
Ask:
N/A
1y Target Est:
13.67
Day's Range:
7.61 - 8.56
52wk Range:
7.56 - 13.25
Volume:
246,900
Avg Vol (3m):
158,539
Market Cap:
186.64M
P/E (ttm):
14.34
EPS (ttm):
0.56
Div & Yield:
N/A (N/A)
GERBER SCIENTIFIC
(NYSE: GRB)| Last Trade: | 7.96 |
| Trade Time: | 3:51PM ET |
| Change: |
0.12 (1.53%)
|
| Prev Close: | 7.84 |
| Open: | 7.61 |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 13.67 |
| Day's Range: | 7.61 - 8.56 |
| 52wk Range: | 7.56 - 13.25 |
| Volume: | 246,900 |
| Avg Vol (3m): | 158,539 |
| Market Cap: | 186.64M |
| P/E (ttm): | 14.34 |
| EPS (ttm): | 0.56 |
| Div & Yield: | N/A (N/A) |
AP
Gerber's 3Q Profit Leaps 41 Percent
Thursday March 6, 9:56 am ET
SOUTH WINDSOR, Conn. (AP) -- Gerber Scientific Inc.'s profit jumped 41 percent in the fiscal third quarter on strong sales to sign and graphics makers, the manufacturing systems maker said Thursday.
Gerber Scientific earned $3.1 million, or 13 cents per share, in the three months ended Jan. 31, compared with profit of $2.2 million, or 10 cents per share, in the fiscal third quarter of last year.
Analysts polled by Thomson Financial forecast, on average, profit of 12 cents per share.
Revenue climbed 11 percent to $152 million from $137.1 million, meeting expectations.
Gerber Scientific makes systems that help manufacturers make things like signs, lenses and packaging.
Chief Executive Marc T. Giles said in a statement that revenue growth was led by the sign-making and specialty-graphics segment.
New Message
Please
login
to post a reply